sVCAM-1 as a Marker of Endothelial Dysfunction associated with Severe Course of a Novel Coronavirus Infection (COVID-19)
Aim. To study the association of the level of endothelial dysfunction marker sVCAM-1 with the severe course of COVID-19.Material and methods. The study included 100 patients with COVID-19, who were divided into 3 groups depending on the degree of lung damage based on the results of computed tomograp...
Saved in:
| Main Authors: | V. I. Podzolkov, A. E. Pokrovskaya, D. D. Vanina, I. I. Shvedov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2872 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gender and age peculiarities of content changes of protein C, von Willebrand factor, vascular cell adhesion molecules sVCAM-1 in patients with acute left ventricle Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2015-04-01) -
Uric acid is an independent factor associated with endothelial dysfunction in type 2 diabetic patients with microalbuminuria
by: XIE Chao, et al.
Published: (2018-01-01) -
Endothelial dysfunction and thrombotic events in patients with severe novel coronavirus infection COVID-19
by: A. A. Lebedeva, et al.
Published: (2022-05-01) -
Association of endothelial dysfunction factors with the presence of unstable atherosclerotic plaques in the coronary arteries
by: Yu. I. Ragino, et al.
Published: (2019-06-01) -
Reduction of the risk of failure to achieve blood pressure control in patients with arterial hypertension and coronary heart disease: the role of quercetin
by: T. M. Solomenchuk, et al.
Published: (2023-04-01)